About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
PEER COMPARISON
Peer
Comparison
Gland Pharma Ltd.
Peer Companies
Price(Rs)
Chg(Rs)
Chg(%)
EPS(Rs.)
TTM P/E
Volume(000's)
1Year Return(%)
Divinded Yield
Book Value
Astrazeneca Pharma I
9139.4
120.7
1.34
73.34
124.61
826
37.03
0.35
305.28
Caplin Point Lab
2331.5
86.35
3.85
46.42
50.23
27217
16.28
0.26
221.22
Pfizer
5203.6
64.95
1.26
176.76
29.44
292
-12.16
3.17
921.84
Anthem Biosciences
863.5
32.75
3.94
9.01
95.8
70012
0
43.62
Panacea Biotec
460.3
26.65
6.15
-1.33
0
30732
31.68
0
53.74
Sanofi India
5052.45
23
0.46
157.4
32.1
665
-29.67
2.32
343.96
Anlon Healthcare
129.3
20.19
18.5
3.86
33.5
908335
0
20.18
Sai Life Sciences
898.1
16.45
1.87
8.27
108.64
30440
0
103.76
Concord Biotech
1635.85
15
0.93
34.15
47.9
1009
-21.36
0.65
173.27
RPG Life Sciences
2399.25
14.65
0.61
110.51
21.71
1159
8.04
1
320.8
Kwality Pharma
983.2
14.2
1.47
41.88
23.48
7339
22.42
0
255.44
Supriya Lifescience
662.3
12.95
1.99
22.13
29.93
7479
4.68
0.15
123.84
Acutaas Chemicals
1472.35
12.35
0.85
23.27
63.28
13104
92.84
0.05
160.19
JB Chem & Pharma
1694.3
11.45
0.68
43.24
39.18
1039
-9.66
0.91
206.14
Dishman Carbogen Amc
277.45
10.65
3.99
-0.24
0
77944
38.28
0
257.05
Coral Laboratories
539.7
10.1
1.91
50.15
10.76
259
-41.79
0.28
496.83
Torrent Pharma
3543.6
10.05
0.28
58.21
60.88
1527
2.66
0.9
224.32
Mercury Laboratories
860
10
1.18
31.42
27.37
1
-18.2
0.41
446.41
Sun Pharma Inds.
1620.25
9.4
0.58
20
81.02
227287
-13.17
0.99
101.45
Ajanta Pharma
2561.7
9.25
0.36
74.91
34.2
1099
-18.68
1.09
289.84
Page
1
of
10
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.